News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sirion Therapeutics U.S. Rights for Eye Treatment to Bausch & Lomb (BOL)



6/3/2010 8:15:01 AM

Tampa Bay Business Journal -- Bausch & Lomb acquired the assets and U.S. rights for Zirgan from Sirion Therapeutics Inc. Financial terms were not disclosed in a release announcing the deal.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES